Drug & Alcohol Testing Market By End User (Criminal Justice System And Law Enforcement Agencies), By Sample Type (Breath Sample, Hair Sample, Urine Sample), By Product & Services (Equipment, Rapid Testing Devices, Oral Fluid Testing Devices, Urine Testing Devices, Consumables, Laboratory Services), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jun 21, 2016

Key Findings


The global drug and alcohol testing market is expected to grow by CAGR of 10.1% during the forecasted period 2016-2022. The major factors contributing towards the growth of market isintensifying world population and increasing use of drugs and alcohol across the globe. The market is also driven by various factors such as portrayal of stringent laws mandating drug and alcohol testing and rising government funding. The increasing drug and alcohol abuse is one of the major factor driving the growth in the global market.

According to National Institute on Drug Abuse, in 2013 around 24.6 million Americans had used illicit drug which is around 9.4% of the total population aged 12 years or older. Although, marijuana drug is used by around 19.8 million of people aged 12 years or older accounted at 7.5% of total people which is high from 14.5 million in 2007. The intensifying world population is also one of the major driver for the growth of drug and alcohol testing market.

According to United Nations (un.org), in 2015 the world population accounted to 7.3 billion at the mid of 2015. Around 60% of world population live in Asia that attributed around 4.4 billion, 16% in Africa, 10% in Europe, 9% in Latin America & Caribbean countries and rest of the 5% in North American region that accountsfor 358 million. However, China is having the largest population in the world followed by India, accounted at 1.4 billion and 1.3 billion respectively. These two countries are holding around 37% of the world population, individually China 19% and India 18%. Though there have been several factors promoting the market but the presence of certain restraining factor is hampering the market such asa defilement of privacy rights in some countries and prohibition on alcohol consumption in numerous Muslim majority countries. The growth ofemerging markets and oral fluid testing are the key opportunities available in the global market. The rising demand from emerging countries offering plaintiff of growth opportunities in the drug and alcohol testing market.


Market Segment Insight


The global drug and alcohol testing market is segmented into end user, product& services, sample type and geography. On the basis of end user, the market is segmented into criminal justice system and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, pain management centers, personal users and workplace and schools.The product& service segment is segmented equipment, rapid testing devices, consumables and laboratory services. The equipment’s is sub divided into breath analyzers, chromatography instruments, immunoassay analyzers. However, the breath analyzers are also sub divided into fuel cell breathlyzers, semiconductor breathlyzers, and other devices. The rapid testing devices are segmented into oral fluid testing devices, urine testing devices. The urine testing devices is also sub segmented into drug testing cups, dip cards, casettes. The consumables are also segmented into assay kits, sample collection cups, calibrators and controls, others. Sample type segment is segmented into breath sample, hair sample, oral fluid sample, urine sample, others. The others may include blood and sweat sample.


Regional Insight


Globally, the drug and alcohol testing market is segmented intoNorth America, Europe, APAC and ROW. North America region holds the largest market share in the global drug and alcohol testing market followed by Europe. In North America, U.S. holds the largest market share. The increasing drug and alcohol abuse in the North America region is stimulating the growth in the global drug and alcohol testing market. Asia Pacific region is expected to grow with eye popping CAGR during forecasted period 2016-2022. The growth in the Asia Pacific drug and alcohol market is influenced by the rising number of drug addicts in the region, intensifying vehicle base in Asian countries such as China and India. The escalating number of road accidents in such countries due to driving under the influence of drugs and alcohols. Growing advancements in alcohol and drug screening devices by Japan is positively contributing to the growth of Asia drug and alcohol testing market. However, rising concern and awareness in respect of benefit of drug and alcohol screening and rise in the level of disposable income in the Asian countries such as China and India is promoting the growth of the market.


Competitive Insights


Some of the keymarket players are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Medtox Diagnostics, Nanogen Inc., Roche Diagnostics, Siemens Healthcare And Thermo Fisher Scientific, Inc.Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market. Roche acquiredInterMune on August, 29, 2014, InterMune is a biotechnology company focused on research and development and commercialization of innovative therapies in pulmonology and fibrotic diseases. InterMune is having a brand image in UE and Canada so by acquiring InterMune the Roche is able to penetrate these markets efficiently.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL DRUG AND ALCOHOL TESTING MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL DRUG AND ALCOHOL TESTING MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL DRUG AND ALCOHOL TESTING MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL DRUG AND ALCOHOL TESTING MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. INCREASING DRUG & ALCOHOL ABUSE 14
3.1.2. PORTRAYAL OF STRINGENT LAWS MANDATING DRUG AND ALCOHOL TESTING 14
3.1.3. INTENSIFYING WORLD POPULATION 14
3.1.4. RISING GOVERNMENT FUNDING 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. A DEFILEMENT OF PRIVACY RIGHTS IN SOME COUNTRIES 14
3.2.2. PROHIBITION ON ALCOHOL CONSUMPTION IN NUMEROUS MUSLIM-MAJORITY COUNTRIES 14
3.3. KEY OPPORTUNITIES 14
3.3.1. ORAL FLUID TESTING 14
3.3.2. GROWING EMERGING MARKET 14
3.4. CHALLENGES 14
3.4.1. PRECISION CONCERNS FOR BREATHALYZERS 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL DRUG AND ALCOHOL TESTING MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL DRUG AND ALCOHOL TESTING MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL DRUG AND ALCOHOL TESTING MARKET– GAP ANALYSIS 15


CHAP 5. GLOBAL DRUG AND ALCOHOL TESTING MARKET BY END USER 2012-2022 ($ MILLION) 16
5.1. GLOBAL CRIMINAL JUSTICE SYSTEM AND LAW ENFORCEMENT AGENCIES MARKET 2012-2022 ($ MILLION) 16
5.2. GLOBAL DRUG TESTING LABORATORIES MARKET 2012-2022 ($ MILLION) 16
5.3. GLOBAL DRUG TREATMENT CENTERS MARKET 2012-2022 ($ MILLION) 16
5.4. GLOBAL HOSPITALS MARKET 2012-2022 ($ MILLION) 16
5.5. GLOBAL PAIN MANAGEMENT CENTERS MARKET 2012-2022 ($ MILLION) 16
5.6. GLOBAL PERSONAL USERS MARKET 2012-2022 ($ MILLION) 16
5.7. GLOBAL WORKPLACE AND SCHOOLS MARKET 2012-2022 ($ MILLION) 16


CHAP 6. GLOBAL DRUG AND ALCOHOL TESTING MARKET BY SAMPLE TYPE 2012-2022 ($ MILLION) 17
6.1. GLOBAL BREATH SAMPLE MARKET 2012-2022 ($ MILLION) 17
6.2. GLOBAL HAIR SAMPLE MARKET 2012-2022 ($ MILLION) 17
6.3. GLOBAL ORAL FLUID SAMPLE MARKET 2012-2022 ($ MILLION) 17
6.4. GLOBAL URINE SAMPLE MARKET 2012-2022 ($ MILLION) 17
6.5. GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 17


CHAP 7. GLOBAL DRUG AND ALCOHOL TESTING MARKET BY PRODUCT & SERVICES 2012-2022 ($ MILLION) 18
7.1. GLOBAL EQUIPMENT MARKET 2012-2022 ($ MILLION) 18
7.1.1. GLOBAL BREATH ANALYZERS MARKET 2012-2022 ($ MILLION) 18
7.1.1.1. GLOBAL FUEL CELL BREATHLYZERS MARKET 2012-2022 ($ MILLION) 18
7.1.1.2. GLOBAL SEMICONDUCTOR BREATHLYZERS MARKET 2012-2022 ($ MILLION) 18
7.1.1.3. GLOBAL OTHER DEVICES MARKET 2012-2022 ($ MILLION) 18
7.1.2. GLOBAL CHROMATOGRAPHY INSTRUMENTS MARKET 2012-2022 ($ MILLION) 19
7.1.3. GLOBAL IMMUNOASSAY ANALYZERS MARKET 2012-2022 ($ MILLION) 19
7.2. GLOBAL RAPID TESTING DEVICES MARKET 2012-2022 ($ MILLION) 19
7.3. GLOBAL ORAL FLUID TESTING DEVICES MARKET 2012-2022 ($ MILLION) 19
7.4. GLOBAL URINE TESTING DEVICES MARKET 2012-2022 ($ MILLION) 19
7.4.1. GLOBAL DRUG TESTING CUPS MARKET 2012-2022 ($ MILLION) 19
7.4.2. GLOBAL DIP CARDS MARKET 2012-2022 ($ MILLION) 19
7.4.3. GLOBAL CASETTES MARKET 2012-2022 ($ MILLION) 19
7.5. GLOBAL CONSUMABLES MARKET 2012-2022 ($ MILLION) 19
7.5.1. GLOBAL ASSAY KITS MARKET 2012-2022 ($ MILLION) 19
7.5.2. GLOBAL CALIBRATORS AND CONTROLS MARKET 2012-2022 ($ MILLION) 19
7.5.3. GLOBAL SAMPLE COLLECTION CUPS MARKET 2012-2022 ($ MILLION) 19
7.5.4. GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 19
7.6. GLOBAL LABORATORY SERVICES MARKET 2012-2022 ($ MILLION) 19


CHAP 8. GLOBAL DRUG AND ALCOHOL TESTING MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 20
8.1. GLOBAL DRUG AND ALCOHOL TESTING MARKET BY REGION 2012-2022 ($ MILLION) 20
8.2. NORTH AMERICA 20
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.1. U.S. 20
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.2.3.2. CANADA 20
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3. EUROPE 20
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3.1. GERMANY 20
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.2. UK 21
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.3. FRANCE 21
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.4. RUSSIA 21
8.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.3.3.5. REST OF EUROPE 21
8.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 22
8.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 22
8.4. ASIA PACIFIC 22
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.4.3.1. CHINA 22
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.4.3.2. INDIA 22
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.4.3.3. JAPAN 22
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 22
8.4.3.4. ROAPAC 22
8.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 23
8.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 23
8.5. REST OF THE WORLD 23
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
8.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.5.3.1. LATIN AMERICA 23
8.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
8.5.3.2. MIDDLE EAST AND AFRICA 23
8.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
8.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23


CHAP 9. COMPETITIVE LANDSCAPE 24
9.1. ABBOTT LABORATORIES 25
9.1.1. COMPANY OVERVIEW 25
9.1.2. SCOT ANALYSIS 25
9.1.3. PRODUCT BENCHMARKING 25
9.1.4. STRATEGIC INITIATIVES 25
9.2. AGILENT TECHNOLOGIES, INC. 25
9.2.1. COMPANY OVERVIEW 25
9.2.2. SCOT ANALYSIS 25
9.2.3. PRODUCT BENCHMARKING 25
9.2.4. STRATEGIC INITIATIVES 25
9.3. ALERE INC. 25
9.3.1. COMPANY OVERVIEW 25
9.3.2. SCOT ANALYSIS 25
9.3.3. PRODUCT BENCHMARKING 25
9.3.4. STRATEGIC INITIATIVES 25
9.4. BIO-RAD LABORATORIES 25
9.4.1. COMPANY OVERVIEW 25
9.4.2. SCOT ANALYSIS 25
9.4.3. PRODUCT BENCHMARKING 25
9.4.4. STRATEGIC INITIATIVES 25
9.5. DRÄGERWERK AG 25
9.5.1. COMPANY OVERVIEW 25
9.5.2. SCOT ANALYSIS 25
9.5.3. PRODUCT BENCHMARKING 25
9.5.4. STRATEGIC INITIATIVES 25
9.6. ELITECH GROUP 25
9.6.1. COMPANY OVERVIEW 25
9.6.2. SCOT ANALYSIS 26
9.6.3. PRODUCT BENCHMARKING 26
9.6.4. STRATEGIC INITIATIVES 26
9.7. LABORATORY CORPORATION OF AMERICA 26
9.7.1. COMPANY OVERVIEW 26
9.7.2. SCOT ANALYSIS 26
9.7.3. PRODUCT BENCHMARKING 26
9.7.4. STRATEGIC INITIATIVES 26
9.8. MEDTOX DIAGNOSTICS 26
9.8.1. COMPANY OVERVIEW 26
9.8.2. SCOT ANALYSIS 26
9.8.3. PRODUCT BENCHMARKING 26
9.8.4. STRATEGIC INITIATIVES 26
9.9. MICROGENICS 26
9.9.1. COMPANY OVERVIEW 26
9.9.2. SCOT ANALYSIS 26
9.9.3. PRODUCT BENCHMARKING 26
9.9.4. STRATEGIC INITIATIVES 26
9.10. NANOGEN INC. 26
9.10.1. COMPANY OVERVIEW 26
9.10.2. SCOT ANALYSIS 26
9.10.3. PRODUCT BENCHMARKING 26
9.10.4. STRATEGIC INITIATIVES 26
9.11. ORASURE TECHNOLOGIES INC. 26
9.11.1. COMPANY OVERVIEW 26
9.11.2. SCOT ANALYSIS 26
9.11.3. PRODUCT BENCHMARKING 26
9.11.4. STRATEGIC INITIATIVES 26
9.12. ROCHE 27
9.12.1. COMPANY OVERVIEW 27
9.12.2. SCOT ANALYSIS 27
9.12.3. PRODUCT BENCHMARKING 27
9.12.4. STRATEGIC INITIATIVES 27
9.13. SHIMADZU, CORP. 27
9.13.1. COMPANY OVERVIEW 27
9.13.2. SCOT ANALYSIS 27
9.13.3. PRODUCT BENCHMARKING 27
9.13.4. STRATEGIC INITIATIVES 27
9.14. SIEMENS HEALTHCARE 27
9.14.1. COMPANY OVERVIEW 27
9.14.2. SCOT ANALYSIS 27
9.14.3. PRODUCT BENCHMARKING 27
9.14.4. STRATEGIC INITIATIVES 27
9.15. THERMO FISHER SCIENTIFIC, INC. 27
9.15.1. COMPANY OVERVIEW 27
9.15.2. SCOT ANALYSIS 27
9.15.3. PRODUCT BENCHMARKING 27
9.15.4. STRATEGIC INITIATIVES 27

TABLE 1 GLOBAL DRUG AND ALCOHOL TESTING MARKET BY END USER 2012-2022 ($ MILLION) 28
TABLE 2 GLOBAL CRIMINAL JUSTICE SYSTEM AND LAW ENFORCEMENT AGENCIES MARKET 2012-2022 ($ MILLION) 28
TABLE 3 GLOBAL DRUG TESTING LABORATORIES MARKET 2012-2022 ($ MILLION) 28
TABLE 4 GLOBAL DRUG TREATMENT CENTERS MARKET 2012-2022 ($ MILLION) 29
TABLE 5 GLOBAL HOSPITALS MARKET 2012-2022 ($ MILLION) 29
TABLE 6 GLOBAL PAIN MANAGEMENT CENTERS MARKET 2012-2022 ($ MILLION) 29
TABLE 7 GLOBAL PERSONAL USERS MARKET 2012-2022 ($ MILLION) 29
TABLE 8 GLOBAL WORKPLACE AND SCHOOLS MARKET 2012-2022 ($ MILLION) 29
TABLE 9 GLOBAL DRUG AND ALCOHOL TESTING MARKET BY SAMPLE TYPE 2012-2022 ($ MILLION) 29
TABLE 10 GLOBAL BREATH SAMPLE MARKET 2012-2022 ($ MILLION) 29
TABLE 11 GLOBAL HAIR SAMPLE MARKET 2012-2022 ($ MILLION) 29
TABLE 12 GLOBAL ORAL FLUID SAMPLE MARKET 2012-2022 ($ MILLION) 29
TABLE 13 GLOBAL URINE SAMPLE MARKET 2012-2022 ($ MILLION) 29
TABLE 14 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 29
TABLE 15 GLOBAL DRUG AND ALCOHOL TESTING MARKET BY PRODUCT & SERVICES 2012-2022 ($ MILLION) 29
TABLE 16 GLOBAL EQUIPMENT MARKET 2012-2022 ($ MILLION) 29
TABLE 17 GLOBAL BREATH ANALYZERS MARKET 2012-2022 ($ MILLION) 29
TABLE 18 GLOBAL FUEL CELL BREATHLYZERS MARKET 2012-2022 ($ MILLION) 29
TABLE 19 GLOBAL SEMICONDUCTOR BREATHLYZERS MARKET 2012-2022 ($ MILLION) 29
TABLE 20 GLOBAL OTHER DEVICES MARKET 2012-2022 ($ MILLION) 29
TABLE 21 GLOBAL CHROMATOGRAPHY INSTRUMENTS MARKET 2012-2022 ($ MILLION) 29
TABLE 22 GLOBAL IMMUNOASSAY ANALYZERS MARKET 2012-2022 ($ MILLION) 29
TABLE 23 GLOBAL RAPID TESTING DEVICES MARKET 2012-2022 ($ MILLION) 29
TABLE 24 GLOBAL ORAL FLUID TESTING DEVICES MARKET 2012-2022 ($ MILLION) 30
TABLE 25 GLOBAL URINE TESTING DEVICES MARKET 2012-2022 ($ MILLION) 30
TABLE 26 GLOBAL DRUG TESTING CUPS MARKET 2012-2022 ($ MILLION) 30
TABLE 27 GLOBAL DIP CARDS MARKET 2012-2022 ($ MILLION) 30
TABLE 28 GLOBAL CASETTES MARKET 2012-2022 ($ MILLION) 30
TABLE 29 GLOBAL CONSUMABLES MARKET 2012-2022 ($ MILLION) 30
TABLE 30 GLOBAL ASSAY KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 31 GLOBAL CALIBRATORS AND CONTROLS MARKET 2012-2022 ($ MILLION) 30
TABLE 32 GLOBAL SAMPLE COLLECTION CUPS MARKET 2012-2022 ($ MILLION) 30
TABLE 33 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 30
TABLE 34 GLOBAL LABORATORY SERVICES MARKET 2012-2022 ($ MILLION) 30
TABLE 35 NORTH AMERICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 36 NORTH AMERICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 30
TABLE 37 NORTH AMERICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 38 U.S. GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 39 U.S. GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 40 CANADA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 41 CANADA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 30
TABLE 42 CANADA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 43 EUROPE GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 44 EUROPE GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 31
TABLE 45 EUROPE GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 46 GERMANY GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 47 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 48 UK GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 49 UK GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 50 ASIA PACIFIC GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 51 ASIA PACIFIC GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 31
TABLE 52 ASIA PACIFIC GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 53 CHINA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 54 CHINA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 55 INDIA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 56 INDIA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 57 JAPAN GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 58 JAPAN GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 59 MIDDLE EAST & AFRICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 60 MIDDLE EAST & AFRICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 61 LATIN AMERICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 32
TABLE 62 LATIN AMERICA GLOBAL DRUG AND ALCOHOL TESTING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 32

FIGURE 1 MARKET SHARE BY REGIONS 32
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 13 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 14 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)